• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MSL
Click for more information
0.00% 12.5¢

MSL SOLUTIONS LIMITED.

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MSL
Ann: Removal from Official List 		31/12/10 0 583
31/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  583 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 413
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  413 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 372
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  372 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 292
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  292 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 222
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  222 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 255
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  255 
MSL
Ann: Final Director's Interest Notice 		30/12/10 0 510
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  510 
MSL
Ann: Initial Director's Interest Notice 		30/12/10 0 428
30/12/10 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  428 

See All Discussions arrow Created with Sketch.

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.